MAR 27 2002 .
ko(4 22 fr
Summary of Safety and Effectiveness Information PerioLase | MILLENNIUM DENTAL
Dental Laser System TECHNOLOGIES, INC.
Premarket Notification, Section 510(k)
DECEMBER 13, 2001
This 510(K) Summary of safety and effectiveness for the Millennium Dental Technologies PerioLase Dental Laser
System is submitted in accordance with the requirements of the SMDA 1990 and following guidance concerning the
organization and content of a 510(K) summary.
Applicant: Millennium Dental Technologies, Inc.
Address: 10929 South Street, Suite 106-B
Cerritos, CA 90703
Contact Person: David M. Harris, Ph.D.
Telephone: (562) 860-2908 — Phone
(562) 860-1799 — FAX
Preparation Date: December 14, 2001
Device Trade Name: PerioLase Dental! Laser
Common Name: Nd:YAG Pulsed Laser
Classification Name: Instrument, Surgical, Powered, Laser
79-GEX
21 CFR 878-48
Legally Marketed Predicate InPulse Pulsed Nd:YAG Laser
Device: PulseMaster Dental Laser
SunLase 800P Laser System
. Dentica Dental Laser
Description of the Millennium The PerioLase is an Nd:YAG laser producing laser emission at
Dental Technologies PerioLase 1064nm. The laser consists of two interconnected sections: The
Dental Laser cabinet which houses the laser head, the power supply, the cooling
system and the microprocessor with control panel; and the fiber
optic delivery system.
Clinical Performance Data: N/A
Summary Basis of Equivalence: The PerioLase is essentially identical to the InPulse Laser System.
The indications for use and intended uses are also identical. There
are no new safety issues.
PerioLase.doc 18

Kolyv272 7
Summary of Safety and Effectiveness irformation PerloLase | MILLENNIUM DENtag 807"
Dental Laser System TECHNOLOGIES, INCs os EM
Promarket Notification, Section 510(k} Eee
amy 02/2002 0 eae
Intended use: The following are the oral-phamngeal indications for use
for which the device will be marketed:
Abscess Incision and Drainage
Apthous Ulcers Treatment
Biopsies Excision and Incision
Crown lengthening
Hemostatic assistance
Fibroma Removal
Frenectomy
Frenotomy
Gingival Incision and Excision
Gingivectomy
Gingivoplasty
Operculectomy
Oral Papillectomy
Tissue retraction for Impression
Vestibuloplasty.
Selective ablation of enamel (first degree) caries
Exposure of unerupted / partially erupted teeth
Implant recovery
Lesion (tumor) removal
Leukoptakia
Pulpotonry
Pulpotomy as adjunct to root canal therapy
Removal of filling material such as gutta percha or
resin as adjunct treatment during root canal retreatment
Sulcular debridement (removal of diseased or inflamed
soft tissue in the periodontal pocket) lo improve
clinical indices including gingival index, gingival
bleeding index, probe depth, attachment level and
sooth mobility
PerioLase.doc 19

eee
: LE DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
6 Nr
"hn Food and Drug Administration
9200 Corporate Boulevard
Rockville MD 20850
MAR 2 7 2002
Milfennium Dental Technologies, Inc.
c/o David M. Harris, Ph.D.
Bio-Medical Consultants, Inc.
4256 Heyer Avenue
Castro Valley, California 94546
Re: K014272
Trade Name: PerioLase Dental Laser
Regulation Number: 878.4810
Regulation Name: Laser surgical instrument for use in general and plastic surgery and in
dermatology /
. Regulatory Class: II
Product Code: GEX
Dated: December 13, 2001
Received: December 27, 2001
Dear Dr. Harris:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and we have determined the device is substantially equivalent (for the
indications for use stated in the enclosure) to devices marketed in interstate commerce prior to
May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have
been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act
(Act) that do not require approval of a premarket approval application (PMA). You may,
therefore, market the device, subject to the general controls provisions of the Act. The general
controls provisions of the Act include requirements for annual registration, listing of devices,
good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
. comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 — Dr. David Harris
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and
additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of
Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of
your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the
regulation entitled, "Misbranding by reference to premarket notification” (21CFR Part 807.97).
Other general information on your responsibilities under the Act may be obtained from the
: Division of Small Manufacturers, International and Consumer Assistance at its toll-free number

(800) 638-2041 or (301) 443-6597 or at its Internet address
http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours, ,

Vian C.\Gevet

for Celia M. Witten, Ph.D., M.D.
Director
Division of General, Restorative
and Neurological Devices Office of Device Evaluation
Center for Devices and
Radiological Health

Enclosure

: Page _1 ff
§10(k) Number : k a S23 72
Device Name(s}: PerloLase Nd:YAG Dental Laser Systent
Intended Use(s) of the Device:
the PerloLase Nd:YAG Dental Laser System is to provide the ability to perform intraoral soft tissue
dental. general, oral maxillo-facial and cosmetic surgery. The PerioLase is intended for ablating,
incising, excising, vaporization and coagulation of soft tissues using a contact fiber optic delivery
system. The device will be used in the following areas: general and cosmetic dentistry
otolan ngologs, arthroscopy, gastroenterology, general surgery, dermalotogy & plastic surgery,
neurosurgery. gynecology, urology, ophthalmology and pulmonary surgery. The following are the
additional orel-pharngeal indications for use for which the device will be marketed:
* Selective ablation of enamel (first degree) caries /
¢ Exposure of unerupted / partially erupted teeth
« — Implant recovery
« — Lesion (tumor) removal
« = Leukoplakia .
¢ = Pulpotomy
« ~=Pulpotomy as adjunct to root canal therapy
¢ Removal of filting material such as gutta percha or resin as adjunct treatment ducing root
canal retreatment
¢ Sulcular debridement {removal of diseased or inflamed soft tissue in the periodontal
pocket) to improve clinical indiccs including gingival index, gingival bleeding index,
ptobe depth, attachment fevel and tooth mobility
PLEASE 00 NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NECESSARY
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use x OR Over-The-Counter Use
(Per 21 CFR 801.109) {Optional format 1-2-96)
(Division Sign-Off)
PerioLase.doc Division of General, Restorative 6
and Neurological Devices
510(k) Number_KG/4a'72

